Amalgamated Financial’s Idexx Laboratories IDXX Stock Holding History

Amalgamated Financial’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$13.2M	Buy	+24,136	New	+$12.7M	0.1%	147

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Amalgamated Financial's IDXX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Idexx Laboratories (IDXX) in Q1 2022: 24,136 shares worth $13.2M. The stake represents 0.1% of the portfolio and ranks #147 among its holdings.

1,033 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

Amalgamated Financial held 24,136 shares of Idexx Laboratories worth $13.2M as of Q1 2022.
Idexx Laboratories was a new Amalgamated Financial position in Q1 2022.
Idexx Laboratories made up 0.1% of Amalgamated Financial's portfolio in Q1 2022, its #147 holding.
1,033 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.